The Risk of Febrile Seizures following Influenza and 13-Valent Pneumococcal Conjugate Vaccines

Project Title The Risk of Febrile Seizures following Influenza and 13-Valent Pneumococcal Conjugate Vaccines
Description

Evidence on the risk of febrile seizures after inactivated influenza vaccine (IIV) and 13-valent pneumococcal conjugate vaccine (PCV13) is mixed. In the FDA-sponsored Sentinel Initiative, we examined risk of febrile seizures after IIV and PCV13 in children 6-23 months of age during the 2013-14 and 2014-15 influenza seasons.

Link
Published Date
Thursday, February 13, 2020
Category
Publications and Presentations
Scroll to Top